What is NDC 19515-822?

19515-822 is the product NDC for Flulaval 2026/2027 (influenza virus vaccine), Influenza a virus a/switzerland/6849/2025 ivr 278 (H1n1) antigen (Uv, Formaldehyde inactivated) 15 ug/.5mL + 2 more ingredients suspension, listed with the FDA by ID Biomedical Corporation of Quebec. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Flulaval 2026/2027 (Influenza virus vaccine).

What is the active ingredient?

Influenza a virus a/switzerland/6849/2025 ivr 278 (H1n1) antigen (Uv, Formaldehyde inactivated), Influenza a virus a/michigan/105/2025 san 049a (H3n2) antigen (Uv, Formaldehyde inactivated), Influenza b virus b/tokyo/eis13-175/2025 antigen (Uv, Formaldehyde inactivated).

ID Biomedical Corporation of Quebec, NDC labeler code 19515. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Flulaval 2026/2027?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Flulaval 2026/2027 NDC 19515-822 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)19515-822Labeler and product segments. Claims need a package NDC.

Product NDC at billing width19515-0822Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
19515-822-52	19515082252	10 SYRINGE in 1 CARTON (19515-822-52) / .5 mL in 1 SYRINGE (19515-822-41)Marketed from Jul 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Flulaval 2026/2027Suffix: 2026/2027
Generic name (nonproprietary): influenza virus vaccine
Active ingredients: Influenza a virus a/switzerland/6849/2025 ivr 278 (H1n1) antigen (Uv, Formaldehyde inactivated) — 15 ug/.5mLInfluenza a virus a/michigan/105/2025 san 049a (H3n2) antigen (Uv, Formaldehyde inactivated) — 15 ug/.5mLInfluenza b virus b/tokyo/eis13-175/2025 antigen (Uv, Formaldehyde inactivated) — 15 ug/.5mL
Dosage form: Suspension
Route: Intramuscular
Labeler: ID Biomedical Corporation of QuebecNDC labeler code 19515
Product type: Vaccine
Marketing category: BLA — Biologics License ApplicationApplication BLA 125163
Marketing start: Jul 1, 2026
Marketing end: Jun 30, 2027
Identifiers: Product ID 19515-822_22a47299-7679-42e2-a61b-a8b6c12848f4SPL ID 22a47299-7679-42e2-a61b-a8b6c12848f4

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Immunization administration (CPT 90460–90474)

Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.

How CPT relates to drug billing

NDC on a medical claim

N419515082252 followed by a unit qualifier and the quantity

Package 19515-0822-52. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 19515-822

What is NDC 19515-822?: 19515-822 is the product NDC for Flulaval 2026/2027 (influenza virus vaccine), Influenza a virus a/switzerland/6849/2025 ivr 278 (H1n1) antigen (Uv, Formaldehyde inactivated) 15 ug/.5mL + 2 more ingredients suspension, listed with the FDA by ID Biomedical Corporation of Quebec. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Flulaval 2026/2027 (Influenza virus vaccine).
What is the active ingredient?: Influenza a virus a/switzerland/6849/2025 ivr 278 (H1n1) antigen (Uv, Formaldehyde inactivated), Influenza a virus a/michigan/105/2025 san 049a (H3n2) antigen (Uv, Formaldehyde inactivated), Influenza b virus b/tokyo/eis13-175/2025 antigen (Uv, Formaldehyde inactivated).
Who is the labeler?: ID Biomedical Corporation of Quebec, NDC labeler code 19515. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Flulaval 2026/2027?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Flulaval 2026/2027 (Influenza virus vaccine) NDC 19515-822